Clopidogrel Response in Acute Ischemic Stroke. The Bochumer CRISP Study "Bo-CRISP"

Completed

Phase N/A Results N/A

Summary of Purpose

The aim of this study was to determine the prevalence rate and risk factors for chemical laboratory clopidogrel low-response (CLR) in the acute phase after an ischemic stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 26 April 2013.

1 Jul 2010 26 Apr 2013 1 Dec 2012 1 Dec 2012 1 Apr 2013 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Conditions

Sponsors

Trial Design

  • Observation: Case-Only
  • Perspective: Prospective
  • Sampling: Non-Probability Sample

Contacts

Not available